Details for New Drug Application (NDA): 018872
✉ Email this page to a colleague
NDA 018872 describes VISKAZIDE, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the VISKAZIDE profile page.
The generic ingredient in VISKAZIDE is hydrochlorothiazide; pindolol. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; pindolol profile page.
The generic ingredient in VISKAZIDE is hydrochlorothiazide; pindolol. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; pindolol profile page.
Summary for 018872
| Tradename: | VISKAZIDE |
| Applicant: | Novartis |
| Ingredient: | hydrochlorothiazide; pindolol |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;5MG | ||||
| Approval Date: | Jul 22, 1987 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 25MG;10MG | ||||
| Approval Date: | Jul 22, 1987 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
